Drug hypersensitivity syndrome

Indian Journal of Dermatology, Venereology and Leprology

Volumn 77, Issue 1, 2011, Pages 7-15

  Kumari, Rashmi ^a   Timshina, Dependra K ^a   Thappa, Devinder Mohan ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

DIDMOHS; DRESS; drug hypersensitivity syndrome

Indexed keywords

ABACAVIR; ALLOPURINOL; ANTIGEN; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CARBAMAZEPINE; DAPSONE; LAMOTRIGINE; MERCAPTOPURINE; METHYLPREDNISOLONE; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; PREDNISONE; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

AGRANULOCYTOSIS; CELL DEATH; DIFFERENTIAL DIAGNOSIS; DRESS SYNDROME; DRUG DETOXIFICATION; DRUG MEGADOSE; DRUG PULSE THERAPY; FACE EDEMA; FEVER; HEPATITIS; HISTOPATHOLOGY; HUMAN; LYMPHADENOPATHY; LYMPHOID HYPERPLASIA; MYOSITIS; NEPHRITIS; PAPULAR RASH; PATCH TEST; PATIENT COUNSELING; PERIORBITAL EDEMA; RASH; REVIEW; SENSITIVITY AND SPECIFICITY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT DURATION;

ANTICONVULSANTS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; INCIDENCE; MALE; PHARMACEUTICAL PREPARATIONS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SYNDROME; TIME FACTORS;

EID: 79952847607     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.74964     Document Type: Review

References (36)

1. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003;4:561-72. (Pubitemid 36995078)
2. Sontheimer RD, Houpt KR. DIDMOHS: A proposed consensus nomenclature for the drug induced delayed multiorgan hypersensitivity syndrome. Arch Dermatol 1998;134:874-5.
3. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: In vitro assessment of risk. J Clin Invest 1988;82: 1826-32. (Pubitemid 19054926)
4. Handfield-Jones SE, Jenkins RE, Whittaker SJ, Besse CP, McGibbon DH. The anticonvulsant hypersensitivity syndrome. Br J Dermatol 1993;129:175-7. (Pubitemid 23250731)
5. Prussick R, Shear NH. Dapsone hypersensitivity syndrome. J Am Acad Dermatol 1996;35:346-9. (Pubitemid 26257276)
6. Knowles SR, Shapiro L, Shear NH. Serious adverse drug reactions induced by minocycline: Report of 13 patients and review of the literature. Arch Dermatol 1996;132:934-9. (Pubitemid 26266936)
7. Gupta AK, Kopstein JB, Shear NH. Hypersensitivity reaction to terbinafine. J Am Acad Dermatol 1997;36:1018-9. (Pubitemid 27265921)
8. Knowles SR, Gupta AK, Shear NH, Sauder D. Azathioprine hypersensitivity-like reactions-a case report and review of the literature. Clin Exp Dermatol 1995;20:353-6.
9. Arellano F, Sacristán JA. Allopurinol hypersensitivity syndrome: A review. Ann Pharmacother 1993;19:337-43. (Pubitemid 23086961)
10. Schlienger, Raymond G, Shear, Neil H. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998;39:S3-7
11. Valliant L. Drug hypersensitivity syndrome: Drug rash with eosinophilia and systemic symptoms. J Dermatolog Treat 1999;10:267-72.
12. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: What is the pathogenesis. Arch Dermatol 2001;137:357-64. (Pubitemid 32240793)
13. Licata AL, Louis ED. Anticonvulsant hypersensitivity syndrome. Compr Ther 1996;22:152-5
14. Silber IB, Epstein JW. The treatment of chorea with phenylethylhydantoin: A study of 28 cases. Arch Pediatr 1934;51:373-82.
15. Knowles SR, Shapiro L, Shear NH. Anticonvulsant hypersensitivity syndrome: Incidence prevention and management. Drug Saf 1999;21:489-501. (Pubitemid 30021105)
16. Tennis P, Stern R. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study. Neurology 1997;49:542-6. (Pubitemid 27368898)
17. Seth D, Kamat D, Monteja J. DRESS syndrome: A practical approach for primary care practitioners. Clin Paediatr (Phila) 2008;47:947-52.
18. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;155:2285-90.
19. Shear N, Spielberg S. Anticonvulsant hypersensitivity syndrome, in-vitro assessment of risk. J Clin Invest 1988;82:1826-32. (Pubitemid 19054926)
20. Haruda F. Phenytoin hypersensitivity: 38 cases. Neurology 1979;29:1480-520.
21. Kleier RS, Breneman DL, Boiko S. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol 1991;127:1361-4.
22. Gupta A, Eggo M, Uetrecht J, Cribb AE, Daneman D, Rieder MJ, et al. Drug induced hypothyroidism: The thyroid as a target organ in hypersensitivity to anticonvulsants and sulfonamides. Clin Pharmacol Ther 1992;51:56-7.
23. Powers NG, Carson NH. Idiosyncratic reactions to phenytoin. Clin Pediatr 1987;25:120-4. (Pubitemid 17039014)
24. Descamp V, Valence A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, et al. Association of human herpes virus 6 infection with drug reaction with eosiniphilia and systemic symptoms. Arch Dermatol 2001;137:301-4. (Pubitemid 32240782)
25. Rieder MJ, Krause R, Bird IA, Dekaban GA. Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLVinfected, and noninfected cells. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:134-40.
26. Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions - new concepts. Clin Exp Allergy 2007;37:989-99. (Pubitemid 46955519)
27. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59:809-20. (Pubitemid 39005820)
28. Mansur AT, Pekcan YS, Goktay F. Anticonvulsant hypersensitivity syndrome: Clinical and laboratory features. Int J Dermatol 2008;47:1184-9.
29. Chopra S, Levell NJ, Cowley G, Gilkes JJ. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol 1996;134:1109-12. (Pubitemid 26183146)
30. Sheretz E, Jegasothy B, Lazarus G. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. J Am Acad Dermatol 1985;12:178-81.
31. Chaidemenos G, Chrysomallis F, Sombolos K, Mourellou O, Ionnides D, Papakonstantinou M. Plasmapheresis in toxic epidermal necrolysis. Int J Dermatol 1997;36:218-21. (Pubitemid 27208324)
32. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-3. (Pubitemid 28483679)
33. Eames P. Adverse reactions to carbamazepine managed by desensitisation. Lancet 1989;1:509-10. (Pubitemid 19063581)
34. Kaur S, Sarkar R, Thami G, Kanwar AJ. Anticonvulsant hypersensitivity syndrome. Paediatr Dermatol 2002;19:142-5. (Pubitemid 34498860)
35. Sierra NM, Garcia B, Marco J, Plaza S, Hidalgo F, Bermejo T. Cross hypersensitivity syndrome between phenytoin and carbamazepine. Pharm World Sci 2005;27:170-4. (Pubitemid 41159965)
36. Seitz CS, Pfeuffer P, Raith P, Bröcker EB, Trautmann A. Anticonvulsant hypersensitivity syndrome: Cross-reactivity with tricyclic antidepressant agents. Ann Allergy Asthma Immunol 2006;97:698-702. (Pubitemid 44851471)